Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 2004 Jan 15;377(Pt 2):517–524. doi: 10.1042/BJ20031420

Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling.

Jacob Cohen 1, Liat Oren-Young 1, Ursula Klingmuller 1, Drorit Neumann 1
PMCID: PMC1223869  PMID: 14527337

Abstract

Erythropoietin (EPO) is the principal hormone regulating the proliferation of erythroid precursors and their differentiation into erythrocytes. Binding of ligand to the cell-surface EPO-R (EPO receptor) induces dimerization and JAK2 (Janus kinase 2)-mediated tyrosine phosphorylation of the receptor. Less than 1% of the EPO-Rs are displayed on the cell surface; most of the receptor molecules are retained in intracellular compartments, including the ER (endoplasmic reticulum). Using pervanadate (PV) as a potent tool to inhibit cellular PTPs (protein tyrosine phosphatases), we demonstrated previously the accumulation of mature (endoglycosidase H-resistant) tyrosine-phosphorylated EPO-R [Cohen, Altaratz, Zick, Klingmuller and Neumann (1997) Biochem. J. 327, 391-397]. In the present study, we investigated the participation of the ER-associated PTP1B in the dephosphorylation of intracellular EPO-R. We demonstrate tyrosine phosphorylation of EPO-R in BOSC-23T cells co-expressing EPO-R and the 'substrate-trapping' mutant form of PTP1B, PTP1B D181A (referred to as PTP1BD). In vivo interaction between EPO-R and PTP1B suggested that PTP1B dephosphorylates the EPO-R intracellularly. Endoglycosidase H resistance of tyrosine-phosphorylated EPO-R in cells expressing PTP1BD suggested that mature EPO-R is dephosphorylated by PTP1B. Stimulation with EPO of cells co-expressing EPO-R and either PTP1BD or PTP1B resulted in an increase or decrease respectively in phosphotyrosine EPO-R. We thus suggest that PTP1B dephosphorylates EPO-stimulated EPO-R and participates in the down-regulation cascade of EPO-mediated signal transduction.

Full Text

The Full Text of this article is available as a PDF (224.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki N., Matsuda T. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b. J Biol Chem. 2000 Dec 15;275(50):39718–39726. doi: 10.1074/jbc.M005615200. [DOI] [PubMed] [Google Scholar]
  2. Bandyopadhyay D., Kusari A., Kenner K. A., Liu F., Chernoff J., Gustafson T. A., Kusari J. Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J Biol Chem. 1997 Jan 17;272(3):1639–1645. doi: 10.1074/jbc.272.3.1639. [DOI] [PubMed] [Google Scholar]
  3. Bauskin A. R., Alkalay I., Ben-Neriah Y. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell. 1991 Aug 23;66(4):685–696. doi: 10.1016/0092-8674(91)90114-e. [DOI] [PubMed] [Google Scholar]
  4. Chen C. A., Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques. 1988 Jul-Aug;6(7):632–638. [PubMed] [Google Scholar]
  5. Cheng A., Bal G. S., Kennedy B. P., Tremblay M. L. Attenuation of adhesion-dependent signaling and cell spreading in transformed fibroblasts lacking protein tyrosine phosphatase-1B. J Biol Chem. 2001 May 9;276(28):25848–25855. doi: 10.1074/jbc.M009734200. [DOI] [PubMed] [Google Scholar]
  6. Chiu Vi K., Bivona Trever, Hach Angela, Sajous J. Bernard, Silletti Joseph, Wiener Heidi, Johnson Ronald L., 2nd, Cox Adrienne D., Philips Mark R. Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol. 2002 May;4(5):343–350. doi: 10.1038/ncb783. [DOI] [PubMed] [Google Scholar]
  7. Cohen J., Altaratz H., Zick Y., Klingmüller U., Neumann D. Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases. Biochem J. 1997 Oct 15;327(Pt 2):391–397. doi: 10.1042/bj3270391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Collins M. K., Downward J., Miyajima A., Maruyama K., Arai K., Mulligan R. C. Transfer of functional EGF receptors to an IL3-dependent cell line. J Cell Physiol. 1988 Nov;137(2):293–298. doi: 10.1002/jcp.1041370212. [DOI] [PubMed] [Google Scholar]
  9. Constantinescu S. N., Huang L. J., Nam H., Lodish H. F. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell. 2001 Feb;7(2):377–385. doi: 10.1016/s1097-2765(01)00185-x. [DOI] [PubMed] [Google Scholar]
  10. Constantinescu SN, Ghaffari S, Lodish HF. The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction. Trends Endocrinol Metab. 1999 Dec;10(1):18–23. doi: 10.1016/s1043-2760(98)00101-5. [DOI] [PubMed] [Google Scholar]
  11. Espanel X., Wälchli S., Gobert R. P., El Alama M., Curchod M. L., Gullu-Isler N., Hooft van Huijsduijnen R. Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases. Endocrine. 2001 Jun;15(1):19–28. doi: 10.1385/endo:15:1:019. [DOI] [PubMed] [Google Scholar]
  12. Flint-Ashtamker Galit, Eisen-Lev Ronit, Cohen Jacob, Jun-shen Huang Lily, Neumann Drorit. Amino acid residues 268-276 of the erythropoietin receptor contain an endocytosis motif and are required for erythropoietin-mediated proliferation. FEBS Lett. 2002 May 8;518(1-3):189–194. doi: 10.1016/s0014-5793(02)02691-1. [DOI] [PubMed] [Google Scholar]
  13. Flint A. J., Tiganis T., Barford D., Tonks N. K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1680–1685. doi: 10.1073/pnas.94.5.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Frangioni J. V., Beahm P. H., Shifrin V., Jost C. A., Neel B. G. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell. 1992 Feb 7;68(3):545–560. doi: 10.1016/0092-8674(92)90190-n. [DOI] [PubMed] [Google Scholar]
  15. Frank Stuart J. Receptor dimerization in GH and erythropoietin action--it takes two to tango, but how? Endocrinology. 2002 Jan;143(1):2–10. doi: 10.1210/endo.143.1.8607. [DOI] [PubMed] [Google Scholar]
  16. Gelderloos J. A., Anderson S. M. Over-expression of protein tyrosine phosphatase 1 (PTP1) alters IL-3-dependent growth and tyrosine phosphorylation. Oncogene. 1996 Dec 5;13(11):2367–2378. [PubMed] [Google Scholar]
  17. Gu Feng, Dubé Nadia, Kim Jin Wook, Cheng Alan, Ibarra-Sanchez Maria de Jesus, Tremblay Michel L., Boisclair Yves R. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling. Mol Cell Biol. 2003 Jun;23(11):3753–3762. doi: 10.1128/MCB.23.11.3753-3762.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Haj Fawaz G., Markova Boyka, Klaman Lori D., Bohmer Frank D., Neel Benjamin G. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem. 2002 Nov 6;278(2):739–744. doi: 10.1074/jbc.M210194200. [DOI] [PubMed] [Google Scholar]
  19. Haj Fawaz G., Verveer Peter J., Squire Anthony, Neel Benjamin G., Bastiaens Philippe I. H. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science. 2002 Mar 1;295(5560):1708–1711. doi: 10.1126/science.1067566. [DOI] [PubMed] [Google Scholar]
  20. Hilton D. J., Watowich S. S., Murray P. J., Lodish H. F. Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):190–194. doi: 10.1073/pnas.92.1.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Huang L. J., Constantinescu S. N., Lodish H. F. The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell. 2001 Dec;8(6):1327–1338. doi: 10.1016/s1097-2765(01)00401-4. [DOI] [PubMed] [Google Scholar]
  22. Ketteler Robin, Heinrich Achim C., Offe Julia K., Becker Verena, Cohen Jacob, Neumann Drorit, Klingmüller Ursula. A functional green fluorescent protein-erythropoietin receptor despite physical separation of JAK2 binding site and tyrosine residues. J Biol Chem. 2002 May 7;277(29):26547–26552. doi: 10.1074/jbc.M202287200. [DOI] [PubMed] [Google Scholar]
  23. Klingmüller U., Lorenz U., Cantley L. C., Neel B. G., Lodish H. F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 1995 Mar 10;80(5):729–738. doi: 10.1016/0092-8674(95)90351-8. [DOI] [PubMed] [Google Scholar]
  24. Kubatzky K. F., Ruan W., Gurezka R., Cohen J., Ketteler R., Watowich S. S., Neumann D., Langosch D., Klingmüller U. Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor. Curr Biol. 2001 Jan 23;11(2):110–115. doi: 10.1016/s0960-9822(01)00018-5. [DOI] [PubMed] [Google Scholar]
  25. Lavoie C., Chevet E., Roy L., Tonks N. K., Fazel A., Posner B. I., Paiement J., Bergeron J. J. Tyrosine phosphorylation of p97 regulates transitional endoplasmic reticulum assembly in vitro. Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13637–13642. doi: 10.1073/pnas.240278097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Levin I., Cohen J., Supino-Rosin L., Yoshimura A., Watowich S. S., Neumann D. Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization. FEBS Lett. 1998 May 8;427(2):164–170. doi: 10.1016/s0014-5793(98)00414-1. [DOI] [PubMed] [Google Scholar]
  27. Li J. P., D'Andrea A. D., Lodish H. F., Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature. 1990 Feb 22;343(6260):762–764. doi: 10.1038/343762a0. [DOI] [PubMed] [Google Scholar]
  28. Liu F., Chernoff J. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. Biochem J. 1997 Oct 1;327(Pt 1):139–145. doi: 10.1042/bj3270139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Livnah O., Stura E. A., Middleton S. A., Johnson D. L., Jolliffe L. K., Wilson I. A. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 1999 Feb 12;283(5404):987–990. doi: 10.1126/science.283.5404.987. [DOI] [PubMed] [Google Scholar]
  30. Lotti L. V., Lanfrancone L., Migliaccio E., Zompetta C., Pelicci G., Salcini A. E., Falini B., Pelicci P. G., Torrisi M. R. Sch proteins are localized on endoplasmic reticulum membranes and are redistributed after tyrosine kinase receptor activation. Mol Cell Biol. 1996 May;16(5):1946–1954. doi: 10.1128/mcb.16.5.1946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Moulin Stéphanie, Bouzinba-Segard Haniaa, Kelly Paul A., Finidori Joëlle. Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure. Cell Signal. 2003 Jan;15(1):47–55. doi: 10.1016/s0898-6568(02)00054-2. [DOI] [PubMed] [Google Scholar]
  32. Myers M. P., Andersen J. N., Cheng A., Tremblay M. L., Horvath C. M., Parisien J. P., Salmeen A., Barford D., Tonks N. K. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem. 2001 Nov 1;276(51):47771–47774. doi: 10.1074/jbc.C100583200. [DOI] [PubMed] [Google Scholar]
  33. Neumann D., Wikström L., Watowich S. S., Lodish H. F. Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes. J Biol Chem. 1993 Jun 25;268(18):13639–13649. [PubMed] [Google Scholar]
  34. Pear W. S., Nolan G. P., Scott M. L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392–8396. doi: 10.1073/pnas.90.18.8392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Posner B. I., Faure R., Burgess J. W., Bevan A. P., Lachance D., Zhang-Sun G., Fantus I. G., Ng J. B., Hall D. A., Lum B. S. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem. 1994 Feb 11;269(6):4596–4604. [PubMed] [Google Scholar]
  36. Rhee J., Lilien J., Balsamo J. Essential tyrosine residues for interaction of the non-receptor protein-tyrosine phosphatase PTP1B with N-cadherin. J Biol Chem. 2000 Dec 5;276(9):6640–6644. doi: 10.1074/jbc.M007656200. [DOI] [PubMed] [Google Scholar]
  37. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A. R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994 Sep 23;78(6):1027–1037. doi: 10.1016/0092-8674(94)90277-1. [DOI] [PubMed] [Google Scholar]
  38. Supino-Rosin L., Yoshimura A., Altaratz H., Neumann D. A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation. Eur J Biochem. 1999 Jul;263(2):410–419. doi: 10.1046/j.1432-1327.1999.00516.x. [DOI] [PubMed] [Google Scholar]
  39. Tiganis T., Bennett A. M., Ravichandran K. S., Tonks N. K. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol. 1998 Mar;18(3):1622–1634. doi: 10.1128/mcb.18.3.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Witthuhn B. A., Quelle F. W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J. N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 1993 Jul 30;74(2):227–236. doi: 10.1016/0092-8674(93)90414-l. [DOI] [PubMed] [Google Scholar]
  41. Yoshimura A., D'Andrea A. D., Lodish H. F. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4139–4143. doi: 10.1073/pnas.87.11.4139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yoshimura A., Longmore G., Lodish H. F. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature. 1990 Dec 13;348(6302):647–649. doi: 10.1038/348647a0. [DOI] [PubMed] [Google Scholar]
  43. Yoshimura A., Zimmers T., Neumann D., Longmore G., Yoshimura Y., Lodish H. F. Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor. J Biol Chem. 1992 Jun 5;267(16):11619–11625. [PubMed] [Google Scholar]
  44. Zabolotny Janice M., Bence-Hanulec Kendra K., Stricker-Krongrad Alain, Haj Fawaz, Wang Yongping, Minokoshi Yasuhiko, Kim Young-Bum, Elmquist Joel K., Tartaglia Louis A., Kahn Barbara B. PTP1B regulates leptin signal transduction in vivo. Dev Cell. 2002 Apr;2(4):489–495. doi: 10.1016/s1534-5807(02)00148-x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES